1[2]Gobel R, Gortzen A, Brauning P. Encephalopathies caused by valproate. Fortschr Neurol Psychiatr, 1999, 67:7-11.
2[3]Ziyeh S, Thiel T, Spreer J, et al. Valproate-induced encephalopathy:assessment with MR imaging and H MR spectroscopy. Epilepsia,2002, 43:1101-1105.
3[4]Sobaniec-Lotowska ME. Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal. Int J Exp Pathol, 2003, 84:115-125.
4O'NEIL M,DUBREY R W,GROCOTT-MASON R M. Valproate encephalopathy and hyperammonaemia [J]. Postgrad Med J, 2002,78:316-317.
5VOSSLER D G,WILENSKY A J, CAWTHON D F, et al. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy [ J ]. Epilepisia,2002,43 ( 2 ) : 154 -159.
6HAMER H M, KNAKE S, SCHOMBURG U, et al. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate [ J ]. Neurology,2000,54 ( 1 ) :230-232.
7OSUNA M T, BURCET J,RANIO L, et al. Hyperammonemic encephalopathy associated with valproate acid [ J ]. Neurologia, 2003,18 ( 6 ) : 347-350.
8FRASER C M, SILLS G J,FORREST G, et al. Effects of antiepileptic drugs on glutamine synthetase activity in mouse brain [ J ]. Br J Pharmacol, 1999,126 : 1634-1638.
10VERROTTI A, GRECO R, MORGESE G,et al. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs [ J ]. Int J Clin Lab Res, 1999,29:36-40.
